Jonas S. Waizenegger
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial.
Journal: Nature communications
Published: April 12, 2024
Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high-dose cytarabine and mitoxantrone.
Journal: British journal of haematology
Published: November 22, 2020
Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma.
Journal: Leukemia
Published: March 05, 2020
Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS).
Journal: Blood
Published: November 28, 2014
Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs.
Journal: Oncotarget
Published: September 28, 2014
Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma.
Journal: Leukemia
Published: April 02, 2014
Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma.
Journal: Blood
Published: August 29, 2013
Analysis and risk assessment of furan in coffee products targeted to adolescents.
Journal: Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment
Published: November 01, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026